6BMZ
Influenza A M2 transmembrane domain bound to a spiroadamantane inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ALS BEAMLINE 8.3.1 |
| Synchrotron site | ALS |
| Beamline | 8.3.1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2016-04-02 |
| Detector | ADSC QUANTUM 315 |
| Wavelength(s) | 1.1158 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 49.620, 72.590, 99.250 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 58.591 - 2.634 |
| R-factor | 0.2307 |
| Rwork | 0.226 |
| R-free | 0.27670 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3lbw |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.437 |
| Data reduction software | MOSFLM |
| Data scaling software | Aimless |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.11.1_2575: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 72.590 | 2.760 |
| High resolution limit [Å] | 2.630 | 2.630 |
| Rmerge | 0.164 | 0.654 |
| Number of reflections | 11007 | 1442 |
| <I/σ(I)> | 8.7 | 3 |
| Completeness [%] | 99.3 | 98.9 |
| Redundancy | 7 | 6.9 |
| CC(1/2) | 0.997 | 0.920 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 7 | 293 | 0.1 M HEPES pH 7, 30% v/v PEG 400, monoolein, spiroadamantane amine |






